Consequently it appears that MRE11 nuclease activity, although protective of genomic integrity in the normal cell phenotype, may be maladaptive in the cancer phenotype by permitting tumor cell viability in the face of exogenous DNA damage from clastogenic therapies and endogenous DNA replication stress. This evidence concerns the gene MRE11 and cancer.